(Q37551105)

21 August 2017

Lopinavir exposure with an increased dose during pregnancy (English)

1 reference

21 August 2017

1 reference

8

Elizabeth Smith

1 reference

21 August 2017

4

Edmund Capparelli

1 reference

21 August 2017

Mark Mirochnick

1

1 reference

21 August 2017

Brookie M Best

2

1 reference

21 August 2017

Alice M Stek

3

1 reference

21 August 2017

Chengcheng Hu

5

1 reference

21 August 2017

Sandra K Burchett

6

1 reference

21 August 2017

Diane T Holland

7

1 reference

21 August 2017

Sreedhar Gaddipati

9

1 reference

21 August 2017

Jennifer S Read

10

1 reference

21 August 2017

PACTG 1026s Study Team

11

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Journal of Acquired Immune Deficiency Syndromes

21 August 2017

1 reference

21 August 2017

49

1 reference

21 August 2017

5

1 reference

21 August 2017

485-491

1 reference

Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Pharmacokinetics of antiretrovirals in pregnant women

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Plasma protein binding of drugs in pregnancy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Reduced lopinavir exposure during pregnancy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study).

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3912695

Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18989231

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Steady-state lopinavir levels in third trimester of pregnancy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18989231

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18989231

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAI.0B013E318186EDD0

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

18989231

1 reference